News and notes from a day in MedCity, Ohio:
Neoprobe Corp. in Dublin has completed a license amendment with Dow Chemical Co. to use antibodies developed at Dow and National Institutes of Health laboratories in Neoprobe’s RIGS surgical oncology system to target cancers including colon, rectal, breast, bladder, ovarian and endometrial, according to a BusinessWire release.
A $3.75 million award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases is aimed at helping a partnership between the University of Cincinnati and Cincinnati Children’s Hospital Medical Center find new ways to use adult stem cells to speed repair of musculoskeletal soft tissue injuries, according to a university release.
Dr. Daryl Thornton, medical director of the Medical Intensive Care Unit at MetroHealth Medical Center, is concerned about the low rates at which people — specifically minorities — donate organs and is calling for primary-care physicians to jump-start that delicate conversation with their patients, the Cleveland Plain Dealer reported.
Talk about bulk shipments, Cardinal Health said Monday it plans to close its Findlay, Ohio, distribution center in April to reduce its nationwide distribution capacity, putting about 115 employees out of work, the Columbus Dispatch reported.
A HealthGrades study ranked clinical quality at St. Vincent Charity Medical Center in Cleveland among the top 5 percent in the nation, putting the Sisters of Charity Health System member on the HealthGrades Distinguished Hospitals for Clinical Excellence list, along with 26 other Ohio hospitals, according to HealthGrades.